arrow
A

Abir Al Ghuzlan

antoine lacassagne centre
H指数:42
被引数:7,428

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors

散发性髓样甲状腺癌的多灶性与低肿瘤分级相关,且与单灶性肿瘤相比,在体细胞驱动基因突变或总生存期方面无差异。

Surgery
IF2.7
2025-10-100
PRE
Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms

不同器官来源的神经内分泌肿瘤G3中p53和Rb状态的诊断相关性: 465高级别神经内分泌肿瘤的免疫组织化学研究

2024-12-130
PRE
Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents
2024-06-141
OA
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study

一项国际多中心研究中甲状腺髓样癌基因组谱与肿瘤特征和临床结局的关系

THYROID
IF6.7
2024-02-0119
OA
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma

预测甲状腺髓样癌无复发生存率的新型预后列线图

2024-01-224
OAAI
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports

烷化剂诱导的甲状腺髓样癌的高肿瘤突变负荷和对免疫检查点抑制剂的反应: 两例病例报告

THYROID
IF6.7
2023-11-011
PRE
Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network
THYROID
IF6.7
2023-10-018
PRE
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms
2023-09-143
OA
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
2023-04-1936
OA